Galectin-9 in physiological and pathological conditions

被引:163
作者
Hirashima, M
Kashio, Y
Nishi, N
Yamauchi, A
Imaizumi, T
Kageshita, T
Saita, N
Nakamura, T
机构
[1] Kagawa Med Univ, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Endocrinol, Miki, Kagawa 7610793, Japan
[3] Kagawa Med Univ, Dept Surg, Miki, Kagawa 7610793, Japan
[4] Hirosaki Univ, Sch Med, Inst brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
[5] Kumamoto Univ, Sch Med, Dept Dermatol, Kumamoto 860, Japan
[6] Kumamoto Univ, Sch Med, Dept Internal Med, Kumamoto 860, Japan
关键词
galectin-9 (Gal-9); eosinophil activation; cancer; apoptosis; prognosis;
D O I
10.1023/B:GLYC.0000014090.63206.2f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 38 条
[1]   Potential roles of galectins in myeloid differentiation into three different lineages [J].
Abedin, MJ ;
Kashio, Y ;
Seki, M ;
Nakamura, K ;
Hirashima, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (05) :650-656
[2]  
AHIRASHIMA M, 1986, CLIN IMMUNOL IMMUNOP, V39, P231
[3]   ADHESION TO FIBRONECTIN PROLONGS EOSINOPHIL SURVIVAL [J].
ANWAR, ARF ;
MOQBEL, R ;
WALSH, GM ;
KAY, AB ;
WARDLAW, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :839-843
[4]  
ASAKURA H, 2003, J IMMUNOL, V169, P5912
[5]   Regulation of galectin-9 expression and release in Jurkat T cell line cells [J].
Chabot, S ;
Kashio, Y ;
Seki, M ;
Shirato, Y ;
Nakamura, K ;
Nishi, N ;
Nakamura, T ;
Matsumoto, R ;
Hirashima, M .
GLYCOBIOLOGY, 2002, 12 (02) :111-118
[6]   Up-regulation of human deoxyribonuclease II gene expression during myelomonocytic differentiation of HL-60 and THP-1 cells [J].
Chou, SF ;
Chen, HL ;
Lu, SC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (01) :48-53
[7]  
FISCHKOFF SA, 1985, CANCER RES, V45, P2065
[8]  
GOMOLIN HI, 1993, BLOOD, V82, P1868
[9]   EOSINOPHIL CHEMOTACTIC FACTORS FROM GRANULOMA OF KIMURAS DISEASE, WITH SPECIAL REFERENCE TO LYMPHOCYTE-T DERIVED FACTORS [J].
HIRASHIMA, M ;
TASHIRO, K ;
SAKATA, K ;
MURAMOTO, K ;
IYAMA, K .
JOURNAL OF LEUKOCYTE BIOLOGY, 1986, 40 (04) :393-405
[10]  
HIRASHIMA M, 1992, LYMPHOKINE CYTOK RES, V11, P331